Skip to search boxSkip to navigationSkip to main content

Clozapine for self-injurious behavior in individuals with borderline personality disorder

  • Central Regional Hospital
Scholary Output:
Contribution to journal
Article
Peer-review

Open access

Sustainable Development Goals

  • SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well

Abstract

Prior reports suggest that clozapine can markedly reduce aggression and self-injurious behavior in patients with borderline personality disorder (BPD). We present a series of four patients with BPD and persistent self-injurious behavior treated with clozapine at a state psychiatric hospital. After treatment with clozapine these patients ceased self-injurious behaviors and aggression, and no longer required intensive levels of observation or restrictive procedures. All were successfully discharged from the hospital soon after initiation of clozapine. Clozapine appears to be efficacious in the management of chronic suicidality, self-injurious behaviors and aggression in patients with severe BPD.

Publication Information

Output type

Scholary Output:
Contribution to journal
Article
Peer-review

Original language

English (US)

Pages from-to (Number of pages)

Pages 272-274 (3 pages)

Journal (Volume, Issue Number)

Therapeutic Advances in Psychopharmacology (Volume 3, Issue 5)

Publication milestones

  • Published - 10/2013

Publication status

Published - 10/2013

ISSN

2045-1253

Publication IDs

  • Scopus: 84998153458

Publication metrics

Metrics

Fractional count
1
Fractional count
0.50
Fractional count
1
Fractional count
0.50
Fractional count
1
Fractional count
1
Scopus
citations
SciVal
FWCI
1.54
SciVal
Author count
2
SciVal
citations
10
SciVal
Paper percentile
66

PlumX, opens in new tab

Captures
57
Citation count
19

Funding Details

T.Z. reports no conflict of interest. J.M. has received grant support from Merck, Roche/Genentech and PsychoGenics, and speakers’ fees from Eli Lilly and Sunovion.
FundersFunding numbers
Genentech
-
Merck
-